Ultragenyx Pharmaceutical
RARE
#3822
Rank
โ‚น288.51 B
Marketcap
โ‚น2,990
Share price
1.61%
Change (1 day)
-18.23%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น288.51 Billion

As of December 2025 Ultragenyx Pharmaceutical has a market cap of โ‚น288.51 Billion. This makes Ultragenyx Pharmaceutical the world's 3822th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น288.51 B-16.12%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น283.93 Billion
by Nasdaq info icon info icon
โ‚น283.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น1.025 T 255.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น395.11 B 36.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น82.21 B-71.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น38.75 B-86.57%๐Ÿ‡บ๐Ÿ‡ธ USA